Public Release: 

IOF-ESCEO congress will focus on advances in the management of musculoskeletal diseases

IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases is major forum for clinical research and health professional education; research findings to be published in 'Osteoporosis International'

International Osteoporosis Foundation

With the ageing of the population, health authorities all over the world are expecting a dramatic increase in the number of people suffering from chronic diseases of bone, muscle and joints. The IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases has become an important educational and research forum to help physicians meet the growing challenge posed by these serious diseases.

Held annually in Europe, the Congress is jointly organized by the International Osteoporosis Foundation (IOF) and the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). In 2014 the Congress will take place from April 2-5 in Seville, Spain.

Delegates will include leading researchers and health professionals from a broad spectrum of specializations, including rheumatology, endocrinology, orthopedics, radiology, general practice, and rehabilitation. CME accreditation is expected (application in process).

Accepted abstracts (submission possible until January 16, 2014) will be published in 'Osteoporosis International', one of the field's most highly cited peer-reviewed journals. Delegates who submit abstracts may be eligible for scholarships and awards: further information is available at


For complete information visit

An outstanding scientific programme is planned:

The scientific programme will include the following plenary lectures by renowned experts:

  • The Lifecourse Epidemiology of Musculoskeletal Ageing - Cyrus Cooper
  • Osteoporosis therapy, beyond fracture prevention - Jonathan D. Adachi
  • Definition, pathophysiology and management of sarcopenia - Roger Fielding
  • Diabetes, obesity, metabolic syndrome and bone - Serge Ferrari
  • Extraskeletal effects of Vitamin D - Bess Dawson Hughes
  • Guidelines and intervention thresholds in osteoporosis - John A. Kanis
  • PTH and bone, lessons from hypoparathyroidism therapy - Roberto Civitelli
  • How long can bone turnover be suppressed? - Socrates Papapoulos

Special topical multi-speaker sessions will focus on these important issues:

  • Efficacy and safety of anti-osteoporosis medications in the elderly
  • Challenges with the development of bone forming agents in Europe
  • Calcium, vitamin D, proteins and women's musculoskeletal health
  • Algorithm for the management of osteoarthritis in Europe
  • Inside the benefit-risk ratio of osteoporosis treatments: a global overview
  • Can we identify which patients should be treated in osteoarthritis?
  • Qualitative and quantitative Adverse Reactions induced by treatment of rheumatic disorders with Glucocorticoids
  • Osteonecrosis of the Jaw Taskforce: IOF international consensus
  • Consideration and proposal for defining a reference case for economic evaluation in osteoarthritis
  • Goal oriented treatment in Osteoporosis
  • Gaucher Disease: A rare disease that often affects bone

To view the complete programme visit

Online abstract submission, registration and hotel booking is available on the congress website:

Key dates

  • Abstract submission deadline: January 16, 2014
  • Pre-registration: March 17, 2014

About IOF

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization devoted to the prevention, diagnosis and treatment of osteoporosis and related diseases of bone, muscles and joints. IOF members, including committees of scientific researchers, patient, medical and research societies, and industry representatives from around the globe, share a common vision of a world without musculoskeletal diseases and fragility fractures. IOF now represents more than 200 societies in all regions of the world. / /


The European Society for Clinical & Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.